Medical equipment firm Hologic updates FY 2025 earnings, projecting EPS of $4.25 to $4.35 amid revenue challenges.

Medical equipment provider Hologic updated its FY 2025 earnings guidance, projecting EPS of $4.25 to $4.35 and revenue of $4.1 billion. The company's Q2 2025 EPS guidance is $1.00 to $1.03. Despite a downgrade in revenue expectations due to currency headwinds and weak breast capital sales, analysts maintain a "Moderate Buy" consensus with a target price of $88.92. Hologic specializes in diagnostics, imaging, and surgical products for women's health.

6 weeks ago
15 Articles

Further Reading